Pyxis Oncology Inc. (PYXS) NASDAQ
$4.31 (0.07) (-1.60%)
Market Cap: $257.88M
As of 05/08/24 12:52 PM EDT. Market open.
Pyxis Oncology Inc. (PYXS)
NASDAQ
$4.31
(0.07) (-1.60%)
Market Cap: $257.88M
As of 05/08/24 12:52 PM EDT. Market open.
Add to Portfolio
pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
70
Address
.
PRICE CHART FOR PYXIS ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.34
Previous Close
$4.38
Days Range
$4.26 - $4.54
52 week range
$1.35 - $6.85
Volume
119,234
Avg. Volume (30 days)
452,589
Market Cap
$257.88M
Dividend Yield
-
P/E
-
Shares Outstanding
58,876,390
Open
$4.34
Previous Close
$4.38
Days Range
$4.26 - $4.54
52 week range
$1.35 - $6.85
Volume
119,234
Avg. Volume (30 days)
452,589
Market Cap
$257.88M
Dividend Yield
-
P/E
-
Shares Outstanding
58,876,390
FINANCIAL STATEMENTS FOR PYXIS ONCOLOGY INC
LOADING...
INSIDER TRANSACTIONS FOR PYXIS ONCOLOGY INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Connealy Pamela Ann | CFO and COO | Nov 29, 2023 | Option Exercise | $1.40 | 36,949 | 51,729 | 781,583 | Nov 30, 2023, 04:15 PM |
Connealy Pamela Ann | CFO and COO | Sep 28, 2023 | Buy | $1.87 | 8,000 | 14,960 | 818,532 | Sep 28, 2023, 04:32 PM |
Wadhane Jitendra | Chief Accounting Officer | Sep 27, 2023 | Buy | $1.87 | 2,500 | 4,675 | 226,937 | Sep 27, 2023, 06:37 PM |
Connealy Pamela Ann | CFO and COO | Sep 27, 2023 | Buy | $1.85 | 6,426 | 11,868 | 810,532 | Sep 27, 2023, 06:36 PM |
Wadhane Jitendra | Chief Accounting Officer | Sep 25, 2023 | Buy | $1.77 | 5,000 | 8,850 | 224,437 | Sep 25, 2023, 05:05 PM |
Connealy Pamela Ann | CFO and COO | Sep 25, 2023 | Buy | $1.67 | 12,000 | 20,044 | 804,106 | Sep 25, 2023, 05:04 PM |
Wadhane Jitendra | Chief Accounting Officer | Sep 22, 2023 | Buy | $1.74 | 2,500 | 4,349 | 219,437 | Sep 22, 2023, 07:35 PM |
Connealy Pamela Ann | CFO and COO | Sep 22, 2023 | Buy | $1.74 | 5,000 | 8,695 | 792,106 | Sep 22, 2023, 07:34 PM |
Sullivan Lara | President and CEO | Sep 18, 2023 | Sale | $2.10 | 8,541 | 17,936 | 2,403,882 | Sep 18, 2023, 07:03 PM |
Sullivan Lara | President and CEO | Sep 14, 2023 | Sale | $2.25 | 100 | 225 | 2,412,423 | Sep 18, 2023, 07:03 PM |
Sullivan Lara | President and CEO | Sep 13, 2023 | Option Exercise | $2.13 | 184,742 | 393,500 | 2,412,523 | Sep 13, 2023, 08:16 PM |
Sullivan Lara | President and CEO | Sep 13, 2023 | Sale | $2.27 | 3,000 | 6,816 | 2,597,265 | Sep 13, 2023, 08:16 PM |
Sullivan Lara | President and CEO | Sep 12, 2023 | Sale | $2.25 | 4,917 | 11,071 | 2,600,265 | Sep 13, 2023, 08:16 PM |
Sullivan Lara | President and CEO | Sep 11, 2023 | Sale | $2.27 | 20,000 | 45,414 | 2,605,182 | Sep 13, 2023, 08:16 PM |
PFIZER INC | 10% Owner | Mar 17, 2023 | Buy | $2.76 | 1,811,594 | 4,999,999 | 5,952,263 | Mar 23, 2023, 04:14 PM |
PFIZER INC | 10% Owner | Mar 17, 2023 | Buy | $2.76 | 1,811,594 | 4,999,999 | 5,952,263 | Mar 21, 2023, 06:07 PM |
Chin Mark | Former Director | Apr 21, 2022 | Sale | $3.05 | 1,745,761 | 5,324,571 | 0 | Apr 25, 2022, 12:12 PM |
Cline Darren S | Director | Dec 08, 2021 | Buy | $9.39 | 10,000 | 93,885 | 10,000 | Dec 09, 2021, 04:18 PM |
Civik Thomas | Director | Nov 18, 2021 | Buy | $12.74 | 15,700 | 200,018 | 15,700 | Nov 19, 2021, 01:21 PM |
Chin Mark | Director | Oct 13, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 1,745,761 | Oct 15, 2021, 05:37 PM |
Cormorant Asset Management, LP | Former 10% Owner | Oct 13, 2021 | Buy | $16.00 | 450,000 | 7,200,000 | 1,118,854 | Oct 15, 2021, 04:12 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Connealy Pamela Ann | CFO and COO | 11/29/2023 | 51,729 |
Connealy Pamela Ann | CFO and COO | 09/28/2023 | 14,960 |
Wadhane Jitendra | Chief Accounting Officer | 09/27/2023 | 4,675 |
Connealy Pamela Ann | CFO and COO | 09/27/2023 | 11,868 |
Wadhane Jitendra | Chief Accounting Officer | 09/25/2023 | 8,850 |
Connealy Pamela Ann | CFO and COO | 09/25/2023 | 20,044 |
Wadhane Jitendra | Chief Accounting Officer | 09/22/2023 | 4,349 |
Connealy Pamela Ann | CFO and COO | 09/22/2023 | 8,695 |
Sullivan Lara | President and CEO | 09/18/2023 | 17,936 |
Sullivan Lara | President and CEO | 09/14/2023 | 225 |
Sullivan Lara | President and CEO | 09/13/2023 | 393,500 |
Sullivan Lara | President and CEO | 09/13/2023 | 6,816 |
Sullivan Lara | President and CEO | 09/12/2023 | 11,071 |
Sullivan Lara | President and CEO | 09/11/2023 | 45,414 |
PFIZER INC | 10% Owner | 03/17/2023 | 4,999,999 |
PFIZER INC | 10% Owner | 03/17/2023 | 4,999,999 |
Chin Mark | Former Director | 04/21/2022 | 5,324,571 |
Cline Darren S | Director | 12/08/2021 | 93,885 |
Civik Thomas | Director | 11/18/2021 | 200,018 |
Chin Mark | Director | 10/13/2021 | 5,000,000 |
Cormorant Asset Management, LP | Former 10% Owner | 10/13/2021 | 7,200,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PYXIS ONCOLOGY INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
HHLR ADVISORS, LTD. | 382,606 | 0.01% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 364,150 | 0.00101% | 68.39% | Other |
BLACKROCK INC. | 310,598 | 0.00001% | 3.01% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 308,241 | 0.00006% | 6.92% | Other |
CHANGE IN SHARES OUTSTANDING FOR PYXIS ONCOLOGY INC
STOCK BUYBACKS FOR PYXIS ONCOLOGY INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
7.62%
1Q
06/30/2023
15.87%
2Q
03/31/2023
25.82%
3Q
12/31/2022
27.82%
4Q
09/30/2022
36.60%
5Q
06/30/2022
37.07%
6Q
03/31/2022
37.64%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PYXIS ONCOLOGY INC
LOADING...